It is a pharma private limited company based in New Delhi, Delhi, India, established in 1993.
1993 | New Delhi, Delhi, India | ActiveSwami Laboratories Private Limited, a active private limited company, was established on 11 May 1993 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232DL1993PTC053493. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Its leadership includes Paras Bajaj (Director), Kanchan Bajaj (Director), Vijay Bajja (Director). Past directors included Paras Bajaj, Rajat Bajaj, Kanchan Bajaj. It holds ₹1.62 Cr open charges and ₹1.35 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2023. It is based at B-1/E-22, Ext. Mohan Cooperative Industrial Estate Mathura Road,, New Delhi, Delhi, 110044.
U24232DL1993PTC053493
053493
11 May 1993
₹6.00 M
₹2.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Swami Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Paras Bajaj | Director | 12 Apr 2017 | Current |
| Kanchan Bajaj | Director | 17 Sep 2020 | Current |
| Vijay Bajja | Director | 11 May 1993 | Current |
| Sanyog Bajaj | Director | 12 Apr 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | 23 Feb 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 25 Apr 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Swami Laboratories Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 35.94% decrease. The company also saw a substantial improvement in profitability, with a 114.49% increase in profit. The company's net worth moved up by a moderate rise of 1.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Swami Laboratories had a promoter holding of 80.02% and a public holding of 19.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹16,196,779.00
₹13,454,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2007 | Centurion Bank Of Punjab Limited | ₹1.37 Cr | Open |
| 28 Jun 2007 | Centurion Bank Of Punjab Limited | ₹2.51 M | Open |
| 22 Oct 2006 | Icici Bank Branch | ₹5.00 M | Satisfied |
| 17 Jul 2006 | Icici Bank Limited | ₹8.45 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Swami Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Swami Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swami Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Swami Laboratories Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was documented.
The activity Swami Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was completed.
The activity Kanchan Bajaj was appointed as a Director was appointed as a Director on 17 Sep 2020 & has been associated with this company since 5 years 2 months . was completed.
Progress on Paras Bajaj was appointed as a Director was appointed as a Director on 12 Apr 2017 & has been associated with this company since 8 years 7 months . was documented.
Progress on Sanyog Bajaj was appointed as a Director was appointed as a Director on 12 Apr 2017 & has been associated with this company since 8 years 7 months . was documented.
Progress on A charge registered on 22 Oct 2006 via Charge ID 10026108 with Icici Bank Branch was fully satisfied on 25 Aug 2007. was documented.
The CIN of Swami Laboratories Private Limited is U24232DL1993PTC053493.
Swami Laboratories Private Limited is headquartered at B-1/E-22, Ext. Mohan Cooperative Industrial Estate Mathura Road,, New Delhi, Delhi, 110044.
Swami Laboratories Private Limited was incorporated on 11 May 1993.
The current directors of Swami Laboratories Private Limited are
The primary industry of Swami Laboratories Private Limited is Pharma.
Swami Laboratories Private Limited is unlisted.
The authorized capital of Swami Laboratories Private Limited is ₹6.00 M, and the paid-up capital is ₹2.00 M.
The compliance status of Swami Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX